GHRP-2 has human studies showing that it can affect growth-hormone and related endocrine signals. That does not prove meaningful muscle gain, fat loss, recovery or longevity benefits in routine use.
Still uncertain: Meaningful muscle gain, fat loss, recovery, longevity or long-term safety.
By confirming your subscription, you agree to receive occasional WhichPeps Evidence Updates. Kit processes the signup and email delivery for WhichPeps. Privacy. Unsubscribe anytime.
What does the evidence mean in simple terms? table
What is it?
Growth-hormone secretagogue hexapeptide
Entity type
Peptide
Research focus
GH-axis physiology
Human evidence
Small human physiology studies show GH release, increased food intake and activation of ACTH/prolactin pathways.
Regulatory status
Not FDA-approved; FDA highlights compounding safety uncertainty.
Main limitations
Meaningful muscle gain, fat loss, recovery, longevity or long-term safety.
Safety
FDA cites immunogenicity concerns and serious adverse-event reports in some clinical contexts; causality may be uncertain.
Evidence reviewed
2026-09-18
i
Small human physiology studies show GH release, increased food intake and activation of ACTH/prolactin pathways.
Outcome-level evidence
Evidence is not one score.
Each record below answers a narrower question about an outcome, population or context. Evidence status and the study finding are shown separately so strong evidence is not mistaken for a positive effect.
FDA cites immunogenicity concerns and serious adverse-event reports in some clinical contexts; causality may be uncertain.
Can stimulate appetite and GH; endocrine effects can extend beyond a simple GH-only narrative. Long-term efficacy and safety for physique use are not established.
Technical details
Mechanism / biologyActivates the ghrelin/GHS receptor to stimulate pituitary GH release.
Route / formulation boundaryAcute hormone release does not prove body-composition or performance benefit.
Identity / data-quality noteUse the canonical compound identity and studied formulation when interpreting evidence.
Study / label regimen evidenceVerified study/label regimen evidence is available. Published human challenge-study regimen. Open descriptive regimen evidence →
WhichPeps does not rely on a single headline study when the evidence base is broader. Primary research, registries, regulators and supporting records are kept distinct.
2structured study records
2outcome records
7linked source records
How to read these counts: they show evidence coverage, not evidence strength. One large, well-designed study can be more informative than several weak or indirect records.
Show supporting and discovery sources
Study pages above contain the records used for public evidence summaries. The links below include supporting, regulatory and literature-discovery sources; a registry or search result is not treated as proof of benefit.
Evidence rule: WhichPeps keeps human, animal, laboratory, regulatory and product/formulation evidence distinct. Common names help people find the page; they do not change the underlying scientific identity.
